Zota Health Care Ltd

ZOTA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,036 cr, stock is ranked 957
High RiskStock is 3.52x as volatile as Nifty
408.703.40 (-0.83%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,036 cr, stock is ranked 957
High RiskStock is 3.52x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-4,937.41
PB RatioPB Ratio
15.64
Dividend YieldDiv. Yield
0.24%
Sector PESector PE
37.57
Sector PBSector PB
5.03
Sector Div YldSctr Div Yld
0.68%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Zota Health Care Ltd. is a pharmaceutical company engaged in the business of manufacturing and marketing of medicines

Investor PresentationView older 

Aug 2, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201820192020202179.3687.1096.59109.067.255.542.73-0.21
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 1.86%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Updates 
Announced OnNov 27, 2021

Zota Health Care LImited has informed the Exchange regarding 'Clearance of Second Phase of Clinical Trial Study of COROVYL Ayruvedic tablet to be used in the management of Corona virus disease'. | Download

Zota Health Care LImited has informed the Exchange regarding 'Clearance of Second Phase of Clinical Trial Study of COROVYL Ayruvedic tablet to be used in the management of Corona virus disease'. | Download

Copy of Newspaper Publication 
Announced OnNov 2, 2021

Zota Health Care LImited has informed the Exchange about Copy of Newspaper Publication | Download

Zota Health Care LImited has informed the Exchange about Copy of Newspaper Publication | Download

Cash Dividend 
Ex. DateSep 22, 2021

Final • Div/Share: ₹ 1

See all events